DPW
WST icon

DiNuzzo Private Wealth’s West Pharmaceutical WST Stock Holding History

DiNuzzo Private Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
8
+1
+14% +$306 ﹤0.01% 554
2026
Q1 		$1.75K Buy
7
+1
+17% +$249 ﹤0.01% 688
2025
Q4 		$1.65K Sell
6
-1
-14% -$274 ﹤0.01% 716
2025
Q3 		$1.73K Buy
7
+5
+250% +$1.22K ﹤0.01% 689
2025
Q2 		$438 Sell
2
-2
-50% -$428 ﹤0.01% 1106
2025
Q1 		$896 Sell
4
-3
-43% -$827 ﹤0.01% 865
2024
Q4 		$2.29K Hold
7
– – ﹤0.01% 549
2024
Q3 		$2.1K Hold
7
– – ﹤0.01% 597
2024
Q2 		$2.31K Buy
7
+1
+17% +$353 ﹤0.01% 471
2024
Q1 		$2.38K Sell
6
-1
-14% -$370 ﹤0.01% 418
2023
Q4 		$2.46K Buy
+7
New +$2.48K ﹤0.01% 369

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DiNuzzo Private Wealth's WST Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its West Pharmaceutical (WST) stake by 14% in Q2 2026, buying an estimated $306 and bringing the position to 8 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

DiNuzzo Private Wealth first reported a position in WST in Q4 2023 and has held it in 11 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • DiNuzzo Private Wealth held 8 shares of West Pharmaceutical worth $2.87K as of Q2 2026.
  • DiNuzzo Private Wealth bought 1 West Pharmaceutical share in Q2 2026, an estimated $306.
  • West Pharmaceutical made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #554 holding.
  • DiNuzzo Private Wealth first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.